Holen Sie sich die Stockscreener-App
9.34
5.66%
-0.56
Handel nachbörslich:
9.32
-0.02
-0.21%
Ginkgo Bioworks Holdings Inc Aktie (DNA) Neueste Nachrichten
Is Ginkgo Bioworks Holdings Inc a good long term investmentSector-Based Investing & Rapid Capital Appreciation - earlytimes.in
ProteoNic 2G UNic® Technology Licensed by Ginkgo Bioworks for BARDA-Supported Consortium Advancing Monoclonal Antibody Manufacturing for Anti-Filovirus Therapies - Investing News Network
Recent Uptick Might Appease Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Institutional Owners After Losing 13% Over the Past Year - 富途牛牛
Ginkgo Bioworks Partners With Deep Origin-Led Team on ARPA-H to Develop Drug Safety Platform - marketscreener.com
Ginkgo Bioworks Partners on Deep Origin-Led Team to Develop New Tools for Pred Predictive Drug Safety - marketscreener.com
Ginkgo Bioworks partners on Deep Origin-led team to develop new tools for predicting drug safety - Finviz
Ginkgo Bioworks partners with Deep Origin on ARPA-H drug safety project - Investing.com UK
Ginkgo Bioworks (NYSE: DNA) to aid ARPA-H CATALYST drug safety modeling platform - Stock Titan
Ginkgo Bioworks (NYSE:DNA) Shares Gap UpWhat's Next? - MarketBeat
Ginkgo Bioworks to Hold Special Meeting of Shareholders - GuruFocus
Ginkgo Bioworks secures $47M contract from PNNL for phenotyping platform - Investing.com
Ginkgo Bioworks secures $47M contract from PNNL for phenotyping platform By Investing.com - Investing.com South Africa
Ginkgo Bioworks Awarded 4-Year Energy Department Contract Valued at Up to $47 Million - marketscreener.com
Ginkgo Bioworks stock rises on $47M DOE contract award By Investing.com - Investing.com South Africa
Ginkgo Bioworks stock rises on $47M DOE contract award - Investing.com India
Ginkgo Bioworks Holdings Inc selected by PNNL to deliver a modular, high-throughput phenotyping platform for DOE's M2PC - marketscreener.com
Ginkgo Bioworks Selected by PNNL to Deliver a Modular, High-Throughput Phenotyping Platform for DOE's M2PC - Finviz
Ginkgo Bioworks Selected by PNNL to Deliver a Modular, High‑Throughput Phenotyping Platform for DOE's M2PC - marketscreener.com
Will Ginkgo Bioworks Holdings Inc. Class stock announce a stock splitCEO Change & AI Based Buy and Sell Signals - Newser
Is Ginkgo Bioworks Holdings Inc. stock a buy before product launchesMarket Rally & Consistent Growth Equity Picks - Newser
Ginkgo Bioworks Holdings, Inc. $DNA Holdings Boosted by Geode Capital Management LLC - MarketBeat
Ginkgo Bioworks Collaborates With Strm.Bio, Partners on ARPA-H Contract for Cell Engineering, Gene Therapy - marketscreener.com
STRM.BIO Awarded ARPA-H Contract to Advance Megakaryocyte-Derived Vesicle Platform for In Vivo Cell Engineering and Gene Therapy - Finviz
Ginkgo Bioworks (NYSE: DNA) partner STRM.BIO lands ARPA-H deal worth up to $8.4M - Stock Titan
Ginkgo Bioworks Holdings (DNA) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
What analysts say about Ginkgo Bioworks Holdings Inc stockMomentum Trading Signals & Low Cost Market Strategies - earlytimes.in
Ginkgo Bioworks Holdings, Inc. $DNA Position Lifted by Legal & General Group Plc - MarketBeat
Ginkgo Bioworks Issues Notice of Settlement of Shareholder Derivative Actions (PR Newswire) - Aktiellt
Retail Trends: Is Ginkgo Bioworks Holdings Inc. stock a contrarian buyJuly 2025 Drop Watch & Risk Managed Investment Signals - BỘ NỘI VỤ
Will Ginkgo Bioworks Holdings Inc. stock recover faster than marketJuly 2025 Gainers & Free Weekly Chart Analysis and Trade Guides - BỘ NỘI VỤ
Ginkgo Bioworks Launches ADME Profiling Service Using Lab Automation, Offering a US-based Operation That Will Match or Beat Pricing Quotes from Chinese or Other International Vendors (PR Newswire) - Aktiellt
(DNA) as a Liquidity Pulse for Institutional Tactics - news.stocktradersdaily.com
How Ginkgo Bioworks Holdings Inc. Class stock compares with tech leaders2025 Geopolitical Influence & AI Forecast for Swing Trade Picks - newser.com
How Ginkgo Bioworks Holdings Inc. Class stock benefits from digital adoptionStop Loss & Weekly High Potential Stock Alerts - newser.com
Will Ginkgo Bioworks (DNA) Leverage ARPA-H Partnership to Advance Its Oral Therapeutics Ambitions? - Yahoo Finance
Ginkgo Bioworks: Scaling Science, Not Revenue (NYSE:DNA) - Seeking Alpha
Is Ginkgo Bioworks Holdings Inc. Class stock resilient in recession scenarios - newser.com
Ginkgo Bioworks Holdings (DNA) Price Target Decreased by 11.11% to 10.88 - MSN
Ginkgo Bioworks Holdings Inc. stock daily chart insightsJuly 2025 Breakouts & Long Hold Capital Preservation Plans - newser.com
Can Ginkgo Bioworks Holdings Inc. stock beat market expectations this quarter - newser.com
Will Ginkgo Bioworks Holdings Inc. stock gain from lower inflationWeekly Market Summary & Real-Time Price Movement Reports - newser.com
Is it time to cut losses on Ginkgo Bioworks Holdings Inc.Trade Exit Summary & AI Based Buy and Sell Signals - newser.com
Exit strategy if you’re trapped in Ginkgo Bioworks Holdings Inc.2025 Institutional Moves & Consistent Profit Trade Alerts - newser.com
Can Ginkgo Bioworks Holdings Inc. stock surprise with earnings upsideEarnings Overview Summary & AI Powered Buy/Sell Recommendations - newser.com
Published on: 2025-11-19 04:21:37 - newser.com
1.08%
0.91%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):